Drug intelligence / Profile preview

Fuganlin Oral Liquid

Development stage
Phase 4
Lead developer
Apichope Pharmaceutical
Administration
Oral
01

Overview

Fuganlin Oral Liquid is a traditional Chinese medicine (TCM) formulation used primarily for the treatment of repeated infantile respiratory tract infections. It is described as a pure Chinese medicinal recipe and has demonstrated efficacy in modulating immune function, providing symptomatic relief for fever, cough, and asthma, as well as exhibiting antiviral, antibacterial, and anti-inflammatory properties. Clinical studies have shown that it can improve outcomes in children with recurrent respiratory infections compared to standard antipyretic treatments. The formulation is also considered safe based on toxicological testing in animal models; however, further clinical trials are required to confirm its safety and efficacy in humans[1][2][6].

Brand names
Fuganlin Oral Liquid
Other names
FGL oral liquidFuGanLin oral liquid
02

Targets

ADRA1 (Alpha-1 adrenergic receptor family)ADRB1 (β1)

Beyond the preview

Go deeper on Fuganlin Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuganlin Oral Liquid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call